Urinary Bladder Neoplasms

"Urinary Bladder Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the URINARY BLADDER.

Descriptor ID	D001749
MeSH Number(s)	C04.588.945.947.960 C12.758.820.968 C12.777.829.813 C13.351.937.820.945 C13.351.968.829.707
Concept/Terms	Urinary Bladder Neoplasms Urinary Bladder Neoplasms Neoplasm, Urinary Bladder Urinary Bladder Neoplasm Neoplasms, Bladder Bladder Neoplasms Bladder Neoplasm Neoplasm, Bladder Bladder Tumors Bladder Tumor Tumor, Bladder Tumors, Bladder Urinary Bladder Cancer Urinary Bladder Cancer Cancer, Urinary Bladder Malignant Tumor of Urinary Bladder Cancer of the Bladder Bladder Cancer Bladder Cancers Cancer, Bladder Cancer of Bladder

Below are MeSH descriptors whose meaning is more general than "Urinary Bladder Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Urogenital Neoplasms [C04.588.945]
Urologic Neoplasms [C04.588.945.947]
Urinary Bladder Neoplasms [C04.588.945.947.960]
Male Urogenital Diseases [C12]
Urogenital Neoplasms [C12.758]
Urologic Neoplasms [C12.758.820]
Urinary Bladder Neoplasms [C12.758.820.968]
Urologic Diseases [C12.777]
Urinary Bladder Diseases [C12.777.829]
Urinary Bladder Neoplasms [C12.777.829.813]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Urogenital Neoplasms [C13.351.937]
Urologic Neoplasms [C13.351.937.820]
Urinary Bladder Neoplasms [C13.351.937.820.945]
Urologic Diseases [C13.351.968]
Urinary Bladder Diseases [C13.351.968.829]
Urinary Bladder Neoplasms [C13.351.968.829.707]

Below are MeSH descriptors whose meaning is related to "Urinary Bladder Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Urinary Bladder Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Urinary Bladder Neoplasms" by people in this website by year, and whether "Urinary Bladder Neoplasms" was a major or minor topic of these publications.

Bar chart showing 78 publications over 21 distinct years, with a maximum of 9 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2003	1	0	1
2004	1	0	1
2005	0	1	1
2006	3	0	3
2007	2	0	2
2008	3	0	3
2009	3	0	3
2012	1	0	1
2013	2	0	2
2014	0	1	1
2015	2	0	2
2016	8	0	8
2017	6	0	6
2018	6	0	6
2019	8	0	8
2020	3	0	3
2021	2	0	2
2022	5	0	5
2023	5	0	5
2024	9	0	9
2025	6	0	6

Below are the most recent publications written about "Urinary Bladder Neoplasms" by people in Profiles.

Heard JR, Pagano I, Rosser C, Tan WS. Hematuria Cancer Risk Score in Combination With Oncuria-Detect for Patients Undergoing Evaluation for Hematuria. Urology. 2026 Jan; 207:178-183.

View in: PubMed
Finocchiaro A, Tylecki A, Vigan? S, Bertini A, Ficarra V, Di Trapani E, Salonia A, Briganti A, Montorsi F, Lughezzani G, Buffi N, Sood A, Rogers C, Abdollah F. Socioeconomic disparities and bladder cancer stage at diagnosis: a statewide cohort analysis. JNCI Cancer Spectr. 2025 Jul 01; 9(4).

View in: PubMed
Pagano I, Zhang Z, Luu M, Tikhonenkov S, Le Calvez-Kelm F, Goodison S, Sakatani T, Murakami K, Kobayashi T, Avogbe P, Kim H, Lee R, Manel A, Vian E, Rosser CJ, Furuya H. Performance of the Oncuria-Detect bladder cancer test for evaluating patients presenting with haematuria: results from a real-world clinical setting. J Transl Med. 2025 Jun 18; 23(1):680.

View in: PubMed
Hsiao CH, Lin YW, Liu CH, Chen YT, Nguyen HT, Chuang AE. Nano-orchestrated magnetotactic-like navigation for electromagnetic theranostics and immune enhancement via photoautotrophic oxygenation, mild hyperthermia, and ferroptosis. J Nanobiotechnology. 2025 Jun 13; 23(1):442.

View in: PubMed
Finocchiaro A, Tylecki A, Stephens A, Vigan? S, Bertini A, Briganti A, Montorsi F, Salonia A, Lughezzani G, Buffi N, Ficarra V, Di Trapani E, Sood A, Rogers C, Abdollah F. Socioeconomic disparities and MIBC survival outcome-An analysis of a statewide cohort. World J Urol. 2025 Jun 02; 43(1):349.

View in: PubMed
Teplitsky SL, Cranford W, Kim JK, Bell S, Strup S, Allison D, Buchanan A, Myint Z, Strup SE, Martin F, Sood A, Kamat AM, McLouth CJ, Hensley PJ. Prognostic significance of pathologic response to neoadjuvant chemotherapy in muscle-invasive urothelial carcinoma of the bladder with histologic subtype. Urol Oncol. 2025 Sep; 43(9):521.e19-521.e27.

View in: PubMed
Steinmetz AR, Pierce M, Martini A, Tholomier C, Manyam G, Chen Y, Sood A, Duplisea JJ, Johnson BA, Czerniak BA, Lee BH, Jagannath C, Yla-Herttuala S, Parker NR, McConkey DJ, Dinney CP, Mokkapati S. Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon a gene therapy in a murine bladder cancer model. Front Immunol. 2024; 15:1387229.

View in: PubMed
Lobo N, Duan Z, Sood A, Zhao H, Lindskrog SV, Dyrskjot L, Giordano SH, Williams SB, Bree KK, Kamat AM. Sex Disparity in Non-muscle-invasive Bladder Cancer: Pitfalls of Large Population-based Data Sets and Lessons from an Integrated Analysis. Eur Urol Oncol. 2025 Jun; 8(3):608-611.

View in: PubMed
Hsiao CH, Lin YW, Liu CH, Nguyen HT, Chuang AE. Light-Driven Green-Fabricated Artificial Intelligence-Enabled Micro/Nanorobots for Multimodal Phototherapeutic Management of Bladder Cancer. Adv Healthc Mater. 2024 12; 13(32):e2402864.

View in: PubMed
Chuang AE, Tao YK, Dong SW, Nguyen HT, Liu CH. Polypyrrole/iron-glycol chitosan nanozymes mediate M1 macrophages to enhance the X-ray-triggered photodynamic therapy for bladder cancer by promoting antitumor immunity. Int J Biol Macromol. 2024 Nov; 280(Pt 4):135608.

View in: PubMed

People

Explore

Similar Concepts

Top Journals